Korify Capital
Korify Capital
Investing in breakthrough technologies
- Use: Go2Market;
- Date closing: -
- Amount: -
- Industry focus: All
- Total budget: 100M $
- Entity type: Venture Capital
- Vertical focus: Biotechnology
- Website: https://korifycapital.com/
- Status: Open
- Funding type: Equity investment;
- Geographic focus:
- Public/Private: Private
- Stage focus: Series B; Series C;
- Applicant target: Startup;
Overview
Korify Capital has launched its first fund, Korify Capital Fund ONE, with the objective of investing in innovative solutions in the biotech sector. With a special focus on longevity and mental health, Korify aims to support those companies that “give people the opportunity to live longer, healthier, and happier lives by both preventing and treating age-related diseases and mental illnesses.”
-Type of companies they invest in:
Targeting biotech startups, the firm usually focuses its investments on late-stage and pre-IPO financing rounds.
The size of the fund is of USD100m.
Portfolio: Atai LIFE SCIENCES, Bionomics, Sensei Biotherapeutics, Alto Neuroscience, LEAF4Life, and Cambrian.
Korify Capital FAQ
Korify Capital Reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
Korify Capital News
Featured Funds
- Usage: Scale-up;
- Entity type: Corporate VC
- Status: Open
- Geographic focus: Brazil; Germany; Israel; India; United States of America; North America; Northern Europe; Latam; Asia;
- 0 reviews 0 questions
- Usage: R&D;
- Entity type: Public Agency
- Total: 30M £
- Funding type: Grant;
- Status: Open
- Geographic focus: United Kingdom;
- 0 reviews 45 questions
- Usage: Scale-up;
- Entity type: Private Equity Firm
- Total: 50M €
- Funding type: Equity investment;
- Status: Open
- Geographic focus: Europe;
- 0 reviews 0 questions